Endometrial Carcinoma
Oncology
3
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
CT
Chia Tai TianQing Pharmaceutical GroupChina - Lianyungang
1 program1
TQB2858 injectionPhase 21 trial
Active Trials
M&
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Chia Tai TianQing Pharmaceutical GroupTQB2858 injection
Zai LabNiraparib
Merck & Co.NP137
Clinical Trials (3)
Total enrollment: 323 patients across 3 trials
A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma
Start: Dec 2021Est. completion: Jul 2023
Phase 2Unknown
Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma
Start: Jun 2021Est. completion: Dec 202683 patients
Phase 2Recruiting
GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab
Start: Dec 2020Est. completion: Jul 2026240 patients
Phase 1/2Active Not Recruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
1h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
1h ago
Office Administrator
SystImmune
1h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
2h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
2h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
2h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 323 patients
3 companies competing in this space